Literature DB >> 9276372

Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung.

S L Tucker1, Z X Liao, E L Travis.   

Abstract

PURPOSE: Recent studies of Liao et al. and Travis et al. have demonstrated that irradiation of cross-sectional partial volumes contiguous to the base of mouse lung produces a higher incidence of pneumonitis than irradiation of equally sized subvolumes contiguous to the apex. One interpretation of this finding is that the critical target cells for pneumonitis are not distributed uniformly throughout the lung. The purpose of the present study was to test this interpretation by obtaining an estimate of the spatial distribution of the critical target cells for pneumonitis in mouse lung, based on the partial-volume data. METHODS AND MATERIALS: A mathematical model was derived describing the probability of radiation pneumonitis as a function of dose, volume of lung irradiated, and location in the lung of the irradiated subvolume. The model includes a nonparametric description of the spatial target-cell distribution in lung, to be estimated from data. The model was fitted to the lethality data of Liao et al. and Travis et al. to obtain estimates of the proportion of target cells contained in each of various subvolumes of the lung.
RESULTS: The results indicate that the critical target cells in mouse lung are concentrated in the base and, to a somewhat lesser extent, in the apex of the lung, with fewer cells in the middle region. The estimated spatial distribution of target cells in mouse lung agrees well with the distribution of alveoli, whose concentration in the midlung is limited by the presence of the major conducting airways.
CONCLUSION: Heterogeneity in the spatial distribution of critical target cells in normal tissue implies that the complication probability (NTCP) depends on the location in the organ of the irradiated subvolume, as well as on radiation dose and subvolume size. Calculations using an NTCP model for mouse lung indicate that irradiation of equal subvolumes of lung with the same dose can lead to complication probabilities covering the full range from 0 to 100%, depending only on the location in the lung of the irradiated subvolume.

Entities:  

Mesh:

Year:  1997        PMID: 9276372     DOI: 10.1016/s0360-3016(97)00131-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Genistein can mitigate the effect of radiation on rat lung tissue.

Authors:  Victoria L Calveley; Salomeh Jelveh; Aimee Langan; Javed Mahmood; Ivan W T Yeung; Jake Van Dyk; Richard P Hill
Journal:  Radiat Res       Date:  2010-05       Impact factor: 2.841

2.  Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.

Authors:  Søren M Bentzen; Louis S Constine; Joseph O Deasy; Avi Eisbruch; Andrew Jackson; Lawrence B Marks; Randall K Ten Haken; Ellen D Yorke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 3.  Nondosimetric risk factors for radiation-induced lung toxicity.

Authors:  Feng-Ming Spring Kong; Shulian Wang
Journal:  Semin Radiat Oncol       Date:  2014-12-15       Impact factor: 5.934

Review 4.  Complications from Stereotactic Body Radiotherapy for Lung Cancer.

Authors:  Kylie H Kang; Christian C Okoye; Ravi B Patel; Shankar Siva; Tithi Biswas; Rodney J Ellis; Min Yao; Mitchell Machtay; Simon S Lo
Journal:  Cancers (Basel)       Date:  2015-06-15       Impact factor: 6.639

Review 5.  Prevention and treatment of radiotherapy-induced side effects.

Authors:  Lara Barazzuol; Rob P Coppes; Peter van Luijk
Journal:  Mol Oncol       Date:  2020-06-24       Impact factor: 6.603

Review 6.  Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer.

Authors:  Anqi Zhang; Fuyuan Yang; Lei Gao; Xiaoyan Shi; Jiyuan Yang
Journal:  Cancer Manag Res       Date:  2022-08-13       Impact factor: 3.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.